Lmr Partners LLP Verona Pharma PLC Transaction History
Lmr Partners LLP
- $9.66 Billion
- Q4 2024
A detailed history of Lmr Partners LLP transactions in Verona Pharma PLC stock. As of the latest transaction made, Lmr Partners LLP holds 48,500 shares of VRNA stock, worth $3.56 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
48,500Holding current value
$3.56 Million% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VRNA
# of Institutions
232Shares Held
68.6MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$470 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$410 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$249 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$230 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$230 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.48B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...